Of note, SLC25A1 inhibition enhanced vulnerability to DNA repair inhibitors of EJ-pathways in irradiated lung and glioblastoma cell line models, without IDH1/2 mutations. This evidence concerns the gene SLC25A1 and glioblastoma.